-
公开(公告)号:US09616115B2
公开(公告)日:2017-04-11
申请号:US15002443
申请日:2016-01-21
申请人: Sanaria Inc.
IPC分类号: A61K39/002 , A61K39/015 , A61K9/00 , A61K31/4706 , A61K39/00
CPC分类号: A61K39/015 , A61K9/0019 , A61K31/4706 , A61K2039/522 , A61K2039/6081 , Y02A50/412
摘要: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.
-
公开(公告)号:US20130224250A1
公开(公告)日:2013-08-29
申请号:US13730294
申请日:2012-12-28
申请人: Sanaria Inc.
IPC分类号: A61K39/015 , A61K31/4706
CPC分类号: A61K39/015 , A61K9/0019 , A61K31/4706 , A61K2039/522 , A61K2039/6081 , Y02A50/412
摘要: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.
-
公开(公告)号:US10272146B2
公开(公告)日:2019-04-30
申请号:US15458792
申请日:2017-03-14
申请人: Sanaria Inc.
IPC分类号: A61K39/002 , A61K39/015 , A61K9/00 , A61K31/4706 , A61K39/00
摘要: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.
-
公开(公告)号:US09241982B2
公开(公告)日:2016-01-26
申请号:US14671003
申请日:2015-03-27
申请人: Sanaria Inc.
IPC分类号: A61K39/015 , A61K9/00 , A61K39/00
CPC分类号: A61K39/015 , A61K9/0019 , A61K31/4706 , A61K2039/522 , A61K2039/6081 , Y02A50/412
摘要: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.
-
公开(公告)号:US08992944B2
公开(公告)日:2015-03-31
申请号:US13730281
申请日:2012-12-28
申请人: Sanaria Inc.
IPC分类号: A61K39/015 , A61K31/4706 , A61K39/00
CPC分类号: A61K39/015 , A61K9/0019 , A61K31/4706 , A61K2039/522 , A61K2039/6081 , Y02A50/412
摘要: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.
摘要翻译: 公开了基本上纯化的疟原虫子孢子和与伴随的非子孢子物质基本分离的疟原虫子孢子的制剂,其中疟原虫子孢子的制剂具有提高的纯度。 同样提供包含纯化的疟原虫子孢子的疫苗和药物组合物。 还提供了提纯疟原虫子孢子的制备方法。
-
公开(公告)号:US08821896B2
公开(公告)日:2014-09-02
申请号:US13730294
申请日:2012-12-28
申请人: Sanaria Inc.
IPC分类号: A61K39/015 , A61K31/4706 , A61K39/00
CPC分类号: A61K39/015 , A61K9/0019 , A61K31/4706 , A61K2039/522 , A61K2039/6081 , Y02A50/412
摘要: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.
摘要翻译: 公开了基本上纯化的疟原虫子孢子和与伴随的非子孢子物质基本分离的疟原虫子孢子的制剂,其中疟原虫子孢子的制剂具有提高的纯度。 同样提供包含纯化的疟原虫子孢子的疫苗和药物组合物。 还提供了提纯疟原虫子孢子的制备方法。
-
-
-
-
-